Targeting gene therapy for achromatopsia
Clinical trials show subretinal agents are safe, well tolerated by patients.
Physicians finessing the pediatric eye examination
Focus on maximizing visual examination by combining methods of detection-based testing.
Gene therapy sparks foveal morphologic changes in LCA
As soon as 2 weeks after treatment, changes occur to foveal layer.
Posterior corneal elevation: Is there a role for premium IOLs?
Trifocal IOLs can, if implanted with caution, be suitable for patients with keratoconus.
Phase 2/3 results show teprotumumab effective treatment option for TED
Sustained findings over long term indicate no rebound of disease.
A patient’s eye movements can unlock diagnosis
First step is ruling out ocular nystagmus, saccadic disorder.
Improving macular pathology detection in telemedicine screening
Dual imaging may reduce costs, unnecessary referrals, telehealth study results show.
Intravitreal injections and endophthalmitis: Does lidocaine gel change the risk of the infection?
This research was a finalist in the 2020 Ophthalmology Times® Research Scholar Honoree Program.
Advancements with preloaded IOL injectors
Physician offers practical advice for the use of systems.
MIGS helping to personalize glaucoma surgery options
Although minimally invasive procedure gives hope, additional research is required.
Timing and earlier neurolept anesthesia for laser-assisted cataract surgery
Administration has minimal impact on patients’ perception of pain.
Real-world outcomes validate intraocular drug delivery method
Ophthalmologists seek methods to control postoperative inflammation.
Advancement in TED treatment is a bright spot
FDA approval of teprotumumab as therapeutic offers hope for patients.
IOL dilemma: Replacement or rescue
Investigators find little difference between the options.
2 Clarke Drive Cranbury, NJ 08512